New eye drop put to the test in healthy volunteers
NCT ID NCT07313722
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing a new eye drop called BT01001 in 32 healthy adults to see if it is safe and how the body processes it. Participants will receive either the eye drop or a placebo (inactive drop) and be monitored for side effects. Since this is a Phase 1 trial in healthy volunteers, there is no direct treatment benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai General Hospital
RECRUITINGShanghai, 200080, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test